Schedule 13D ownership disclosure

AERPIO PHARMACEUTICALS INC COM

Security class unavailable · CUSIP: 00810B105

Event date: 2021-05-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-21-003006
Form type
SC 13D
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Jun 04, 2021
Reporting period
May 27, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub